Merit Financial Group »

Relay Therapeutics shares owned by Merit Financial Group

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $107k 21k 5.22
2025-06-30 $71k 21k 3.46

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Us Vlu (IUSV)
Ishares Tr Core S&p Us Gwt (IUSG)
Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Spdr Series Trust Portfli Intrmdit (SPTI)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Eafe Value Etf (EFV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Merit Financial Group

Top funds holding Relay Therapeutics

Sb Investment Advisers
Commodore Capital
Point72 Asset Management
BlackRock
Casdin Capital
Vanguard Group
Bellevue Group
Tang Capital Management
State Street Corporation
Nextech Invest
Geode Capital Management
Kynam Capital Management
Dimensional Fund Advisors
MPM Oncology Impact Management
Goldman Sachs Group

View all funds holding Relay Therapeutics